US Patent Issued to EpiVario on Oct. 14 for "ACSS2 inhibitors and methods of use thereof" (Israeli, British, American Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,689, issued on Oct. 14, was assigned to EpiVario Inc. (Philadelphia).

"ACSS2 inhibitors and methods of use thereof" was invented by Philippe Nakache (Ness Ziona, Israel), Omri Erez (Rehovot, Israel), Simone Botti (Rehovot, Israel), Andreas Goutopoulos (Boston) and Harry Finch (Bedfordshire, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to novel ACSS2 inhibitors having activity as anti-cancer therapy, treatment of alcoholism, and viral infection (e.g., CMV), composition and methods of preparation thereof, and uses thereof for treating viral infection, alcoholism, alcoholic steatohepatitis (ASH), non-alcoho...